Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif

Bizhan Romani1, Susan Engelbrecht, Richard H Glashoff

  • 1Division of Medical Virology, Department of Pathology, University of Stellenbosch, Tygerberg Campus, Tygerberg, South Africa. Bizhan@sun.ac.za

Archives of Virology
|August 12, 2009
PubMed

Insights

Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like (APOBEC) proteins exhibit antiviral properties against HIV-1 by hypermutating viral DNA. However, HIV-1 Vif protein suppresses this activity, and further research into these mechanisms could yield new therapeutic strategies.

Area of Science:

  • Biochemistry
  • Virology
  • Molecular Biology

Background:

  • APOBEC proteins possess cytidine deaminase activity and some exhibit antiviral properties.
  • APOBEC3G and APOBEC3F are known to inhibit HIV-1 replication by hypermutating viral DNA in the absence of HIV-1 Vif.
  • The mechanisms by which HIV-1 Vif suppresses APOBEC proteins are not fully understood.

Purpose of the Study:

  • To review the antiviral activities of APOBEC proteins against HIV-1.
  • To discuss the mechanisms of HIV-1 Vif-mediated suppression of APOBEC proteins.
  • To highlight the need for further research into APOBEC-Vif interactions for potential therapeutic development.

Main Methods:

  • Literature review of studies on APOBEC proteins and HIV-1.
  • Analysis of the known antiviral functions of APOBEC family members.
  • Examination of the molecular mechanisms of HIV-1 Vif antagonism.

Main Results:

  • APOBEC3G and APOBEC3F are incorporated into HIV-1 virions and hypermutate viral DNA, inhibiting infectivity.
  • HIV-1 Vif protein counteracts APOBEC activity by preventing their incorporation into virions.
  • While some APOBECs show antiviral activity, others require further investigation.

Conclusions:

  • APOBEC proteins are a crucial host defense mechanism against HIV-1.
  • Understanding Vif's suppression of APOBECs is key to developing novel anti-HIV therapies.
  • Further research into APOBEC-Vif interactions may uncover exploitable targets for combating HIV-1 infection.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...